Riyad Capital on Thursday decreased the price target for Saudi Arabian medical services company and pharmacy operator Al-Dawaa Medical Services (SASE:4163) to 45 Saudi riyals from 50 riyals and kept its neutral rating.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)